gemcitabine has been researched along with betadex in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avola, R; Cardile, V; Eleonora Graziano, AC; Pistarà, V; Rescifina, A; Stancanelli, R; Surdo, E; Tommasini, S; Ventura, CA | 1 |
| Athanasopoulos, A; Berg, K; Boukos, N; Bugnicourt-Moreira, L; Charalambidis, G; Coutsolelos, AG; Gonçalves, AR; Grigalavicius, M; Ladavière, C; Mavroidi, B; Panagiotakis, S; Pelecanou, M; Regagnon, T; Theodossiou, TA; Yannakopoulou, K | 1 |
2 other study(ies) available for gemcitabine and betadex
| Article | Year |
|---|---|
Gemcitabine anticancer activity enhancement by water soluble celecoxib/sulfobutyl ether-β-cyclodextrin inclusion complex.
Topics: A549 Cells; Antineoplastic Agents; beta-Cyclodextrins; Celecoxib; Deoxycytidine; Drug Compounding; Drug Synergism; Gemcitabine; Humans; Molecular Dynamics Simulation; Powders; Solubility; Water | 2019 |
Small anticancer drug release by light: Photochemical internalization of porphyrin-β-cyclodextrin nanoparticles.
Topics: Antineoplastic Agents; beta-Cyclodextrins; Drug Carriers; Gemcitabine; Humans; Nanoparticles; Porphyrins | 2023 |